Scientists probe diabetes Drug's surprising cholesterol side effect
NCT ID NCT03269058
Summary
This study aimed to understand why some patients with type 2 diabetes experience an increase in 'bad' cholesterol when taking the medication dapagliflozin. It involved 28 participants who were randomly assigned to take either the drug or a placebo for six months. Researchers tracked how the body produces and clears cholesterol to learn how to better manage this potential side effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Dijon Bourgogne
Dijon, 21079, France
Conditions
Explore the condition pages connected to this study.